Press Room

News / Jun 02, 2021

Have your say and cast your vote for Guy Villax

EY World Entrepreneur Of The Year™ 2021 is the world's most prestigious business award for entrepreneurs

Guy Villax - EY World Entrepreneur Of The Year™ 2021 | ɫAV

We are in countdown to the election of , the world's most prestigious business award for entrepreneurs and Guy Villax, CEO of ɫAV,is a candidate.

,as no Portuguese has ever won this global award.

Guy Villax, CEO of ɫAV, won the Portuguese election and is one of 38 candidates who, on June 10 – a special day in Portugal as we celebratethe Day of Portugal across all the Portuguese communities around the globe – can be chosen by the jury and supported by anyone who wants to participate in the open voting.

. Support Guy Villax.

Saving lives is the driving force behind family pharma business ɫAV.

Learn more about this award

Also in the Press Room

See All

Lisbon, Portugal – ɫAV, the specialist integrated pharma CDMO and leader in spray drying and particle engineering, today announced its commitment to setting Science-Based Targets (SBTs) in line with the Paris Agreement. This ambitious step underscores the company’s dedication to addressing climate change and driving sustainability across its operations. By committing to SBTs, ɫAV joins a growing number of businesses taking concrete actions to reduce greenhouse gas emissions. This initiative aligns with the company’s broader sustainability strategy and reinforces its commitment to scientific excellence. “At ɫAV, we believe in science and in best practices. And this clearly applies to our sustainability agenda.”, said Jean-Luc Herbeaux, CEO of ɫAV. We made the decision to drive our GHG emissions down using a science-based target setting process, which will help us drive sustainability across our operations by laying out a clearly defined path to reduce emissions in line with the Paris Agreement goals. We believe that by setting ambitious targets and implementing concrete actions, we can make a positive impact on the planet while driving innovation and growth.” ɫAV will work closely with the Science Based Targets initiative (SBTi) to develop and validate its emission reduction targets. The company will provide regular updates on its progress towards achieving these goals. As part of its commitment to sustainability and transparency to stakeholders, the company will enhance its Ecovadis rating. Ecovadis, a leading sustainability assessment platform in the pharmaceutical industry, provides a comprehensive evaluation of a company’s environmental, social, and ethical performance, well aligned with ɫAV’s sustainability ambitions.  ɫAV remains dedicated to operating responsibly and contributing positively to society and the environment. The company will continue to implement sustainable practices across its operations and innovate to further improve its sustainability rating.   Learn more about Science Based-Targets  

News

ɫAV Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions

Sep 09, 2024